| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/15/2007 | CN101015353A Pure natural oxygenation health care beverage and compounding process thereof |
| 08/15/2007 | CN101015344A Method for preparing health care green onion |
| 08/15/2007 | CN101015313A Lotus-leaf lotus-plumule herb tea |
| 08/15/2007 | CN101015310A Lotus-leaf lotus-plumule tea |
| 08/14/2007 | US7256217 Prodrugs of excitatory amino acids |
| 08/14/2007 | US7256215 Crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative |
| 08/14/2007 | US7256194 Compounds that inhibit factor Xa activity |
| 08/14/2007 | US7255879 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 08/14/2007 | CA2394572C Fusion protein having enhanced in vivo activity of erythropoietin |
| 08/14/2007 | CA2223414C Heteroaryl diol acids as leukotriene antagonists |
| 08/14/2007 | CA2206758C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/09/2007 | WO2007090068A2 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif) |
| 08/09/2007 | WO2007088343A2 Granular material comprising water- insoluble inorganic phosphate binders |
| 08/09/2007 | WO2007059952A3 1-benzazepine-3-sulfonylamino-2-pyrrloridones as factor xa inhibitors |
| 08/09/2007 | WO2006114105A8 Use of modified factor vii for treating bleeding |
| 08/09/2007 | US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 08/09/2007 | US20070185037 Sulfated oligosaccharide derivatives |
| 08/09/2007 | US20070184114 Formulation for topical non-invasive application in vivo |
| 08/09/2007 | CA2633762A1 Unit dose comprising water-insoluble inorganic phosphate binder |
| 08/08/2007 | EP1816138A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 08/08/2007 | EP1816127A1 Triazine derivatives for use as selective npy (y5) antagonists |
| 08/08/2007 | EP1815867A1 Combination drug for treating autoimmune disease |
| 08/08/2007 | EP1815247A2 Therapeutic use of farnesyltransferase inhibitors and methods of monitoring the efficacy thereof |
| 08/08/2007 | EP1814577A2 Use of baff to treat sepsis |
| 08/08/2007 | EP1814553A2 Gtpase inhibitors and use thereof for controlling platelet hyperactivity |
| 08/08/2007 | EP1532111B1 2,5-disubstituted 3-mercaptopentanoic acid |
| 08/08/2007 | EP1347979B1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 08/08/2007 | EP1343530B1 Oral pharmaceutical composition containing a block copolymer |
| 08/08/2007 | EP0837129B1 Epimorphin antagonist and process for producing the same |
| 08/08/2007 | EP0706376B2 Anti-angiogenic compositions and methods of use |
| 08/08/2007 | CN1330669C Recombinant targeted infuse protein for promoting thrombocytopoiesis and its preparation method |
| 08/08/2007 | CN1330370C Stabilized albumin preparaions |
| 08/08/2007 | CN1330303C Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k |
| 08/08/2007 | CN1330296C Propolis soft capsule and its preparation method |
| 08/08/2007 | CN101014591A Novel substituted thiophenecarboxamides, their production and their use as medicaments |
| 08/08/2007 | CN101014566A Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds |
| 08/08/2007 | CN101014357A Combination therapies employing platelet aggregation drugs |
| 08/08/2007 | CN101014326A Medical emulsion of perfluororganic compounds and method for the production thereof |
| 08/08/2007 | CN101011574A Use of an anti-il6 receptor antibody for preparing pharmaceutical composition |
| 08/08/2007 | CN101011573A Production of high molecular mass lectins |
| 08/08/2007 | CN101011545A Method for extracting effective sites group of smilax China root |
| 08/08/2007 | CN101011538A Hemiplegia rapid recovery capsule(pill) and preparation technique thereof |
| 08/08/2007 | CN101011519A Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 08/08/2007 | CN101011499A Linaloe leaf extract, pharmaceutical and health care uses thereof |
| 08/08/2007 | CN101011498A Traditional Chinese medicine preparation for reinforcing body fluid and nourishing the blood, its preparation method and quality control method |
| 08/08/2007 | CN101011496A Tea for activating blood circulation and removing stasis |
| 08/08/2007 | CN101011479A Use of root of prunus mume(sieb.) sieb er Zuce arbidol in preparing drugs for hepatitis and hepatitis B cirrhosis ascites |
| 08/08/2007 | CN101011472A Medicine with blood vessel filling function |
| 08/08/2007 | CN101011441A Externally used medicine for vasculitis and varicosevein |
| 08/08/2007 | CN101011409A Collunarium containing vitamin B12 |
| 08/08/2007 | CN101011397A Pantoprazole sodium freeze dried injection and preparation method thereof |
| 08/08/2007 | CN101011151A Health care bamboo salt and its preparing method |
| 08/08/2007 | CN101011084A Milk for regulating organism immunity and its preparation |
| 08/07/2007 | US7253281 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea |
| 08/07/2007 | US7253199 Azole derivatives and pharmaceutical compositions containing them |
| 08/07/2007 | US7253194 Compounds and inhibitors of phospholipases |
| 08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
| 08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
| 08/07/2007 | US7252799 Methods for sterilizing preparations containing albumin |
| 08/07/2007 | CA2373252C Long lasting anti-angiogenic peptides |
| 08/07/2007 | CA2301799C Novel conjugates of opioids and endogenous carriers |
| 08/07/2007 | CA2163112C A coagulation factor viii formulation |
| 08/07/2007 | CA2092718C Use of protective agents against reactive oxygen species |
| 08/02/2007 | WO2007087428A2 Thrombopoietic compounds |
| 08/02/2007 | WO2007087148A1 Crystalline forms of 3-biphenyl-4-yl-(2s)-[(4'-trifluoromethyl-biphenyl-4-carbonyl)-amino]-propionic acid, and methods of use |
| 08/02/2007 | WO2007086361A1 Ameliorating agent for aluminum storage disease |
| 08/02/2007 | WO2007085084A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | WO2006133391A3 Improved treatment for anemia using a hif-alpha stabilising agent |
| 08/02/2007 | WO2006073361A9 Novel pyridine compounds |
| 08/02/2007 | US20070179601 Methods and apparatus for stenting comprising enhanced embolic protections coupled with improved protections against restenosis and trombus formation |
| 08/02/2007 | US20070179593 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protecions against restenosis and thrombus formation |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179192 Thrombopoietin mimetics |
| 08/02/2007 | US20070179187 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents |
| 08/02/2007 | US20070179139 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases |
| 08/02/2007 | CA2650072A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | CA2635498A1 Thrombopoietic compounds |
| 08/01/2007 | EP1813624A1 Methods and compositions for the prevention and treatment of anemia |
| 08/01/2007 | EP1813611A1 1-substituted-3- beta-d-glucopyranosylated nitrogenous hetero- cyclic compounds and medicines containing the same |
| 08/01/2007 | EP1813294A1 Adhesion preventive and method of preventing adhesion |
| 08/01/2007 | EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 08/01/2007 | EP1507760B1 Cyanoguanidine prodrugs |
| 08/01/2007 | EP1373194B1 BENZAMIDE INHIBITORS OF FACTOR Xa |
| 08/01/2007 | EP1294714B1 Thrombin receptor antagonists |
| 08/01/2007 | EP1242098B1 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 08/01/2007 | EP1148882B1 Use of a plasma homocysteine content reducing agent for the reduction of the thromboembolic side effect risk induced by gestagen type hormones |
| 08/01/2007 | CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 08/01/2007 | CN1329359C Ether compounds, compositions, and uses thereof |
| 08/01/2007 | CN1329078C Agents promoting proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells |
| 08/01/2007 | CN1329069C Hemostatic mastic and formulating method thereof |
| 08/01/2007 | CN1329039C Medicine for treating leukopenia and its preparing method |
| 08/01/2007 | CN101010102A Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils |
| 08/01/2007 | CN101007173A Anti-angiogene compositions and methods of use |
| 08/01/2007 | CN101007124A A traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparation method |
| 08/01/2007 | CN101007081A Preparation method of dropping pills of burnet for raising white cell |
| 08/01/2007 | CN101007057A Extraction method of water soluble components from salvia miltiorrhiza by ultrasonic continuous countercurrent gradient |
| 08/01/2007 | CN101007055A Preparation method of pollen of eucommia ulmoides soft capsules containing alpha-linolenic acid |
| 08/01/2007 | CN101007053A Capsule for treating gynecological diseases and preparation method and quality-control method |